Skip to main content
Janelle (Gehring) Meyer, MD, Oncology, Salem, OR

JanelleMarie(Gehring)MeyerMD

Oncology Salem, OR

Assistant Professor, Medicine, Loyola University of Chi Stritch School of Medicine

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

  • Office

    875 Oak St SE
    Ste 4030
    Salem, OR 97301
    Phone+1 503-561-6444

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2009 - 2012
  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2005 - 2009
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - Present
  • OR State Medical License
    OR State Medical License 2009 - 2025
  • IL State Medical License
    IL State Medical License 2012 - 2017
  • AZ State Medical License
    AZ State Medical License 2008 - 2009
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Oregon Oncology Specialists Integrate AI-Screening Solution VIPER™ into Network to Expand Patient Access to Clinical Trials
    Oregon Oncology Specialists Integrate AI-Screening Solution VIPER™ into Network to Expand Patient Access to Clinical TrialsApril 16th, 2021